Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 75, Issue 1, Pages 237-239Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2016.02.1148
Keywords
depression; iPLEDGE; isotretinoin; patient health questionnaire-2; patient health questionnaire-9; screening; suicidal ideation
Categories
Ask authors/readers for more resources
Isotretinoin is used to treat severe and recalcitrant acne. Possible side effects include depression, suicide, and suicidal ideation; however, other studies suggest isotretinoin may improve mood and quality of life. Although iPLEDGE consenting warns about the risk of depression and suicidal ideation, there is no recommendation for screening tools. The patient health questionnaire-2 and the patient health questionnaire-9 are validated instruments that enable dermatologists to efficiently screen for depression before and after isotretinoin is initiated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available